CDY 1.43% 7.1¢ cellmid limited

Ann: Midkine Symposium Munich, page-68

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 153 Posts.
    lightbulb Created with Sketch. 9

    Rocket,

    When I posted the above, I was thinking more of Cellmid funds available, absence of business partner still, and of Einstein's Saying of "doing the same thing over and over and expecting a different result etc etc".

    However, you do make a valid point in my opinion. The amount of cancer research going on worldwide right now  is huge, and just look at our daily lives now compared with even just a few years ago. Just about everything we use now is better, quicker , easier and even cheaper, from cars, to power tools, coffee makers, concrete, building materials, and that's not even  mentioning pharmaceuticals, let alone the medical subject here. There is work going on everywhere to improve our daily lives( and make lots of money).


    I am not suggesting that Midkine may be getting redundant, but what about all that research?? Is there a better protein marker in the offing, or even a better genetic way of achieving the same result?


    I don't know either. Just thinking out loud. Not looking for a fight.





     

    Last edited by phillit: 31/01/19
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.